In this week’s episode PODCAST-19, we discuss the news that AstraZeneca’s COVID-19 vaccine trial has been suspended due to a serious side effect for a participant, and how the temporary shutdown from a trial can sometimes mean that the process is working as expected.
Par Anna Rothschild and Sinduja Srinivasan
Don’t want to miss an episode of PODCAST-19, FiveThirtyEight’s weekly look at what we know – and what we know we don’t know – about COVID-19? Subscribe to your favorite podcasting app. For example, here’s where to do it on Podcasts Apple and Spotify.
![Kyrie Irving ‘let [his] teammates down,” says Dave Bing – .](https://i0.wp.com/www.fr24news.com/a2/wp-content/uploads/2022/01/1642666120_Kyrie-Irving-‘let-his-teammates-down-says-Dave-Bing-–.jpeg?resize=218%2C150&ssl=1 "Kyrie Irving ‘let [his] teammates down,” says Dave Bing – .")
